UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006641
Receipt number	R000007855
Scientific Title	A Phase 2 study of Docetaxel and Bevacizumab as the second line treatment for patients with non-squamous non-small cell lung cancer previously treated with platinum-based chemotherapy.
Date of disclosure of the study information	2011/11/07
Last modified on	2011/11/01 12:59:41

---